MimiVax’s SurVaxM cancer vaccine improved overall survival in a Phase [...]

BridgeBio has secured FDA Priority Review for its oral infigratinib [...]

ViiV Healthcare’s long-acting HIV treatment Cabenuva achieved superior viral suppression [...]

Aravax will present topline Phase 2 clinical trial results for [...]

Laverock Therapeutics is expanding its therapeutic pipeline into in vivo [...]

AstraZeneca’s Trixeo has been approved in the EU as a [...]

Telix has agreed to acquire ITM Isotope Technologies Munich in [...]

Andelyn Biosciences is manufacturing Ultragenyx’s newly FDA-approved Fayuvi gene therapy [...]

Ariadne Bio has launched with funding from The Michael J [...]

MaaT Pharma plans to advance a global Phase 3 trial [...]